• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BIM-Ken:基于知识增强生物网络识别疾病相关的微小RNA生物标志物

BIM-Ken: Identifying Disease-Related miRNA Biomarkers Based on Knowledge-Enhanced Bio-Network.

作者信息

Zhang Yanhui, Dong Kunjie, Sun Wenli, Gao Zhenbo, Zhang Jianjun, Lin Xiaohui

机构信息

School of Computer Science and Technology, Dalian University of Technology, Dalian 116024, China.

Department of Gastric Surgery, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang 110042, China.

出版信息

Genes (Basel). 2025 Jul 28;16(8):902. doi: 10.3390/genes16080902.

DOI:10.3390/genes16080902
PMID:40869950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12386105/
Abstract

The identification of microRNA (miRNA) biomarkers is crucial in advancing disease research and improving diagnostic precision. Network-based analysis methods are powerful for identifying disease-related biomarkers. However, it is a challenge to generate a robust molecular network that can accurately reflect miRNA interactions and define reliable miRNA biomarkers. To tackle this issue, we propose a disease-related miRNA biomarker identification method based on the knowledge-enhanced bio-network (BIM-Ken) by combining the miRNA expression data and prior knowledge. BIM-Ken constructs the miRNA cooperation network by examining the miRNA interactions based on the miRNA expression data, which contains characteristics about the specific disease, and the information of the network nodes (miRNAs) is enriched by miRNA knowledge (i.e., miRNA-disease associations) from databases. Further, BIM-Ken optimizes the miRNA cooperation network using the well-designed GAE (graph auto-encoder). We improve the loss function by introducing the functional consistency and the difference prompt, so as to facilitate the optimized network to keep the intrinsically important characteristics of the miRNA data about the specific disease and the prior knowledge. The experimental results on the public datasets showed the superiority of BIM-Ken in classification. Subsequently, BIM-Ken was applied to analyze renal cell carcinoma data, and the defined key modules demonstrated involvement in the cancer-related pathways with good discrimination ability.

摘要

微小RNA(miRNA)生物标志物的识别对于推进疾病研究和提高诊断精度至关重要。基于网络的分析方法在识别疾病相关生物标志物方面很强大。然而,生成一个能够准确反映miRNA相互作用并定义可靠miRNA生物标志物的稳健分子网络是一项挑战。为了解决这个问题,我们通过结合miRNA表达数据和先验知识,提出了一种基于知识增强生物网络(BIM-Ken)的疾病相关miRNA生物标志物识别方法。BIM-Ken通过基于包含特定疾病特征的miRNA表达数据检查miRNA相互作用来构建miRNA合作网络,并且网络节点(miRNAs)的信息通过来自数据库的miRNA知识(即miRNA-疾病关联)得到丰富。此外,BIM-Ken使用精心设计的图自动编码器(GAE)优化miRNA合作网络。我们通过引入功能一致性和差异提示来改进损失函数,以便促进优化后的网络保留关于特定疾病的miRNA数据和先验知识的内在重要特征。在公共数据集上的实验结果表明BIM-Ken在分类方面具有优越性。随后,BIM-Ken被应用于分析肾细胞癌数据,所定义的关键模块显示出参与癌症相关途径且具有良好的区分能力。

相似文献

1
BIM-Ken: Identifying Disease-Related miRNA Biomarkers Based on Knowledge-Enhanced Bio-Network.BIM-Ken:基于知识增强生物网络识别疾病相关的微小RNA生物标志物
Genes (Basel). 2025 Jul 28;16(8):902. doi: 10.3390/genes16080902.
2
A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.一种用于局限性透明细胞肾细胞癌的基于预后微小RNA的特征:Bio-miR研究
Br J Cancer. 2025 May 7. doi: 10.1038/s41416-025-03008-2.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Inferring disease-associated microRNAs in heterogeneous networks with node attributes.利用节点属性在异质网络中推断疾病相关的微小RNA
IEEE/ACM Trans Comput Biol Bioinform. 2018 Sep 28. doi: 10.1109/TCBB.2018.2872574.
5
A comprehensive investigation of identifying miRNA biomarkers and their potential role in age-related cataract by meta-analysis and bioinformatics analysis.通过荟萃分析和生物信息学分析全面研究鉴定与年龄相关性白内障相关的miRNA生物标志物及其潜在作用。
Graefes Arch Clin Exp Ophthalmol. 2025 Jan 6. doi: 10.1007/s00417-024-06723-3.
6
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.仑伐替尼联合帕博利珠单抗治疗未经治疗的晚期肾细胞癌:系统评价和成本效果分析。
Health Technol Assess. 2024 Aug;28(49):1-190. doi: 10.3310/TRRM4238.
7
GAM-MDR: probing miRNA-drug resistance using a graph autoencoder based on random path masking.GAM-MDR:基于随机路径掩蔽的图自动编码器探测 miRNA 耐药性
Brief Funct Genomics. 2024 Jul 19;23(4):475-483. doi: 10.1093/bfgp/elae005.
8
New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.从单细胞 lncRNA 表达分析中获得胶质母细胞瘤精准治疗的新见解。
J Cancer Res Clin Oncol. 2021 Jul;147(7):1881-1895. doi: 10.1007/s00432-021-03584-9. Epub 2021 Mar 11.
9
Deciphering Shared Gene Signatures and Immune Infiltration Characteristics Between Gestational Diabetes Mellitus and Preeclampsia by Integrated Bioinformatics Analysis and Machine Learning.通过综合生物信息学分析和机器学习破译妊娠期糖尿病和子痫前期之间共享的基因特征及免疫浸润特征
Reprod Sci. 2025 May 15. doi: 10.1007/s43032-025-01847-1.
10
Transcriptome analysis reveals crucial oncogenic and tumor suppressor miRNAs in lung adenocarcinoma.转录组分析揭示肺腺癌中关键的致癌和抑癌微小RNA。
Lung Cancer. 2025 Aug;206:108540. doi: 10.1016/j.lungcan.2025.108540. Epub 2025 Apr 17.

本文引用的文献

1
Identifying the potential miRNA biomarkers based on multi-view networks and reinforcement learning for diseases.基于多视图网络和强化学习的疾病潜在 miRNA 生物标志物识别。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad427.
2
EGeRepDR: An enhanced genetic-based representation learning for drug repurposing using multiple biomedical sources.EGeRepDR:一种基于遗传的增强型表示学习方法,用于利用多种生物医学源进行药物再利用。
J Biomed Inform. 2023 Nov;147:104528. doi: 10.1016/j.jbi.2023.104528. Epub 2023 Oct 18.
3
scMIC: A Deep Multi-Level Information Fusion Framework for Clustering Single-Cell Multi-Omics Data.
scMIC:一种用于聚类单细胞多组学数据的深度多层信息融合框架。
IEEE J Biomed Health Inform. 2023 Dec;27(12):6121-6132. doi: 10.1109/JBHI.2023.3317272. Epub 2023 Dec 5.
4
HMDD v4.0: a database for experimentally supported human microRNA-disease associations.HMDD v4.0:一个实验支持的人类 microRNA-疾病关联数据库。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1327-D1332. doi: 10.1093/nar/gkad717.
5
An Integrated Method Based on Wasserstein Distance and Graph for Cancer Subtype Discovery.基于 Wasserstein 距离和图的癌症亚型发现综合方法。
IEEE/ACM Trans Comput Biol Bioinform. 2023 Nov-Dec;20(6):3499-3510. doi: 10.1109/TCBB.2023.3293472. Epub 2023 Dec 25.
6
Netrank: network-based approach for biomarker discovery.Netrank:基于网络的生物标志物发现方法。
BMC Bioinformatics. 2023 Jul 29;24(1):304. doi: 10.1186/s12859-023-05418-6.
7
Improving the identification of miRNA-disease associations with multi-task learning on gene-disease networks.利用基因疾病网络的多任务学习提高 miRNA-疾病关联的识别。
Brief Bioinform. 2023 Jul 20;24(4). doi: 10.1093/bib/bbad203.
8
Graph convolutional network-based feature selection for high-dimensional and low-sample size data.基于图卷积网络的高维小样本数据特征选择。
Bioinformatics. 2023 Apr 3;39(4). doi: 10.1093/bioinformatics/btad135.
9
Defining disease-related modules based on weighted miRNA synergistic network.基于加权 miRNA 协同网络定义疾病相关模块。
Comput Biol Med. 2023 Jan;152:106382. doi: 10.1016/j.compbiomed.2022.106382. Epub 2022 Nov 29.
10
Construction and validation of a novel ten miRNA-pair based signature for the prognosis of clear cell renal cell carcinoma.一种基于十个miRNA对的新型特征用于透明细胞肾细胞癌预后评估的构建与验证
Transl Oncol. 2022 Nov;25:101519. doi: 10.1016/j.tranon.2022.101519. Epub 2022 Aug 20.